Yumo Xie: h-index, Total Citations, and Citation Map
Yumo Xie's h-index is 11 (13 i10-index, 691+ total citations across 31+ publications) according to Google Scholar as of May 2026. Yumo Xie is affiliated with Postdoctoral Research Fellow, Fred Hutchinson Cancer Center.
Yumo Xie is a researcher affiliated with Postdoctoral Research Fellow, Fred Hutchinson Cancer Center, specializing in Gastrointestinal cancer. Their work has been cited 691 times. This profile visualizes their global influence, highlighting strong citation networks in China.
Yumo Xie's Citation Metrics
Bibliometric impact based on 31 indexed publications.
- H-Index
- 11
- i10-Index
- 13
- Total Citations
- 691
- Citing Countries
- 24
As of May 2026.
Yumo Xie has an h-index of 11 and 691 total citations across 31 publications, with research cited by institutions in 24 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Yumo Xie's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Top Cited Works
Tip: clickto hide a row from the map
Gastrointestinal cancers in China, the USA, and Europe
2021257
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Significant Contributions
Auto-detected research lines — a seminal paper and the follow-up work building on it. Review and edit before using in a petition. Each Free PDF opens in a new tab — EB-1A organises this into the structure USCIS applies to Criterion 5 of 8 CFR § 204.5(h)(3)(v); EB-1B re-frames it under § 204.5(i)(3) (outstanding researcher); NIW presents it under prong 2 of Matter of Dhanasar.
276 citing papers could not be classified (no author data) — excluded from the percentages above.
The researcher established a foundational comparative analysis of gastrointestinal cancer epidemiology across major regions, subsequently advancing prognostic research by investigating CD103-positive immune cell markers in colorectal cancer.
The researcher elucidated how CSF1R signaling in colorectal cancer modulates tumor-associated macrophages, extending this framework to epigenetic senescence and metabolic regulation of immune evasion.
The researcher developed a prognostic framework integrating systemic inflammation markers and surveillance protocols to refine survival predictions and management strategies for rectal cancer patients.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
